RMEI Continuing Medical Education Neuroscience

Neuroscience CE Activities

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

0.75 CE Credit(s)

Spinal Muscular Atrophy: An Interprofessional Approach

0.75 CE Credit(s)

Stronger for Longer: Managing Chronic Active ABMR in Renal Allograft Recipients: A Care Team Forum®

1.0 CE Credit(s)

Realizing the Promise of Interprofessional Care and Collaboration in Multiple Sclerosis

0.5 CE Credit(s)

Case-based Discussion on the Interprofessional Management of Non-Motor Symptoms in Patients with Parkinson’s Disease

CE Credit Expired

When Small Steps are GIANT LEAPS: Treating Spinal Muscular Atrophy

0.50 CE Credit(s)

The Evolving Role of Orexin-Based Therapy in Narcolepsy Type 1 Management

0.75 CE Credit(s)

Clearing the Path for the Accurate Diagnosis and Optimal Treatment of Bipolar Depression: A Clinical Convergence^®

0.75 CE Credit(s)

Neuroscience blog

Improving the Management of Chronic Neurodegenerative Diseases with Interprofessional Collaboration & Care

Multiple sclerosis (MS) and Parkinson’s disease (PD) are 2 highly prevalent chronic progressive neurodegenerative disorders. Over time, the accumulation and subsequent worsening of the symptoms associated with these diseases can result in disability, impaired quality of life, loss of independence, and an increased burden on caregivers.

Neuroscience
Blog

New Treatments for SMA: Should We Offer Them to Adults?

Spinal muscular atrophy (SMA) is a genetic disorder and a devastating diagnosis for children and their families that can lead to death or a lifetime of severe disability and progressively limited mobility.

Neuroscience
Blog

RMEI DECISION SUPPORT AIDS

The Evolving Role of Orexin-Based Therapy in Narcolepsy Type 1 Management

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

Neuroscience
Decision Support Aid

Clearing the Path for the Accurate Diagnosis and Optimal Treatment of Bipolar Depression: A Clinical Convergence®

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

Neuroscience, Psychiatry
Decision Support Aid

LATEST NEUROSCIENCE ARTICLES

Latest Neuroscience Articles

Hemotympanum with a Basilar Skull Fracture April 18, 2024
A 15-year-old boy presented with a 1-hour history of hearing loss and pain in the left ear after he had tripped and fallen on the street. An otoscopic examination of the left ear showed blood behind the tympanic membrane.
Carlos Carazo Casas, Marimar Medina Gonzalez
Case 12-2024: A 58-Year-Old Woman with Confusion, Aphasia, and Abnormal Head Imaging April 18, 2024
A 58-year-old woman was transferred to the hospital after 16 months of waxing and waning confusion and aphasia and evolving changes on MRI of the head. A diagnosis was made.
Jenny J. Linnoila, Otto Rapalino, Melissa A. Walker, Maria Martinez-Lage
Science behind the Study: CAR T-Cell Therapy for Glioblastoma April 11, 2024
Glioblastoma is the most formidable of primary brain tumors, owing to its aggressive nature and the limited efficacy of the best available treatment, which comprises maximal safe surgical resection, radiotherapy, and alkylating chemotherapy. Most patients die within a year after diagnosis, which underscores the urgent need for innovative therapeutic strategies....
Misty R. Jenkins, Katharine J. Drummond

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.

Allergy & Immunology
2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Gastroenterology
2021

Neuroscience CE Activities

Neuroscience blog

Improving the Management of Chronic Neurodegenerative Diseases with Interprofessional Collaboration & Care

New Treatments for SMA: Should We Offer Them to Adults?

RMEI DECISION SUPPORT AIDS

The Evolving Role of Orexin-Based Therapy in Narcolepsy Type 1 Management

Clearing the Path for the Accurate Diagnosis and Optimal Treatment of Bipolar Depression: A Clinical Convergence®

LATEST NEUROSCIENCE ARTICLES

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

Previously Published CE Activities